Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Orbimed Capital Gp Vii Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   0    

Indirect Shares

   28,157,598      
Direct Value   $0    

Indirect Value

   $507,980,680      
Total Shares   28,157,598      
Total Value   $507,980,680      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    4    

     Stock price went up :
    3   
    0    
     Stock price went down :
    10   
    4    
   
     Gain/Loss Ratio :
   0.0   
   -4.0   
     Percentage Gain/Loss :
   -38.0%
 -137.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synthorx, Inc. THOR 10% Owner 2018-12-11 0 2018-12-11 5,316,355    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT 10% Owner 2020-02-03 0 2022-06-24 415,142    Premium*  
            Passage Bio, Inc. PASG 10% Owner 2020-02-28 0 2023-06-28 8,034,000    Premium*  
            Enliven Therapeutics Ord Shs ELVN Director, 10% Owner 2020-03-12 0 2021-07-16 4,199,068    Premium*  
            Sierra Oncology Inc SRRA Director, 10% Owner 2022-07-01 0 2022-07-01 0    Premium*  
            Third Harmonic Bio, Inc. THRD Director, 10% Owner 2022-09-19 0 2022-09-19 5,779,071    Premium*  
            Galecto Inc. GLTO 10% Owner 2023-04-05 0 2023-08-15 1,510,375    Premium*  
            Theseus Pharmaceuticals, Inc. THRX Director, 10% Owner 2023-07-17 0 2023-07-17 650,600    Premium*  
            Q32 Bio Inc QTTB 0 2024-03-25 2,252,987    Premium*  
* Premium Members only  

Records found :    43         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
THOR Synthorx, Inc. 10% Owner   –       –       •   2018-12-11 4 B $11.00 $14,999,996 I/I 1,363,636 1,363,636 1.5 -
THOR Synthorx, Inc. 10% Owner   –       –       •   2018-12-11 4 A $0.00 $0 I/I 3,952,719 5,316,355 0 -
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2020-02-03 4 B $17.00 $9,501,096 I/I 558,888 176,500 2.25 -
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2020-02-04 4 A $0.00 $0 I/I 4,114,962 606,286 0 -
PASG Passage Bio, Inc. 10% Owner   –       –       •   2020-02-28 4 B $18.00 $6,719,400 I/I 373,300 373,300 1.5 -
PASG Passage Bio, Inc. 10% Owner   –       –       •   2020-03-03 4 A $0.00 $0 I/I 5,574,023 5,947,323 0 -
ELVN Enliven Therapeutics Ord ... Director   –       •       •   2020-03-12 4 B $16.00 $15,000,000 I/I 937,500 937,500 2.25 -
ELVN Enliven Therapeutics Ord ... Director   –       •       •   2020-03-16 4 A $0.00 $0 I/I 1,594,902 2,532,402 0 -
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2020-10-02 4 B $25.00 $12,400,000 I/I 496,000 902,286 2.25 %
ELVN Enliven Therapeutics Ord ... Director   –       •       •   2021-07-16 4/A B $6.00 $9,999,996 I/I 1,666,666 4,199,068 2.25 -
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-11 4 B $5.53 $45,346 I/I 8,200 5,955,523 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-12 4 B $5.65 $565,000 I/I 100,000 6,055,523 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-13 4 B $5.52 $230,736 I/I 41,800 6,097,323 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-14 4 B $5.60 $57,680 I/I 10,300 6,107,623 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-18 4 B $5.46 $626,262 I/I 114,700 6,222,323 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-19 4 B $5.11 $221,263 I/I 43,300 6,265,623 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-20 4 B $5.42 $2,000,522 I/I 369,100 6,634,723 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-01-20 4/A B $5.00 $254,000 I/I 50,800 6,316,423 1.5 -
ARQT Arcutis Biotherapeutics, ... 10% Owner   –       –       •   2022-04-06 4 S $20.69 $6,893,991 I/I (333,204) 731,082 0 %
ARQT Arcutis Biotherapeutics, ... 10% Owner   –       –       •   2022-04-07 4 S $20.66 $7,127,617 I/I (344,996) 553,886 0 %
ARQT Arcutis Biotherapeutics, ... 10% Owner   –       –       •   2022-04-08 4 S $20.71 $4,142,000 I/I (200,000) 451,086 0 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-05-03 4 B $1.93 $427,495 I/I 221,500 6,537,923 1.5 %
PASG Passage Bio, Inc. 10% Owner   –       –       •   2022-05-04 4 B $1.94 $588,790 I/I 303,500 6,841,423 1.5 %
ARQT Arcutis Biotherapeutics, ... 10% Owner   –       –       •   2022-06-24 4 S $21.31 $7,287,402 I/I (341,971) 415,142 0 %
SRRA Sierra Oncology Inc Director   –       •       •   2022-07-01 4 D $55.00 $108,062,350 I/I (1,964,770) 0 0 -
  43  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us